PubMed HealthSearch

PubMed · 3277767

Current thinking on spondarthritides.

Abstract

In this article I have briefly considered current thinking in the field of spondarthritis. Etiopathogenetic aspects include the structure of the HLA-B27 molecule and the population distribution of B27, as well as the significance of bacterial infection in the disease process. Diagnostic aspects have focused on infrared thermography, radionuclide scintigraphy, and computerized tomography. The current therapeutic position involves the traditional combination of NSAID, exercises, and surgery, as well as a new interest in sulfasalazine.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J M Moll. 1988. Current thinking on spondarthritides.. https://pubmed.ncbi.nlm.nih.gov/3277767/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells.

Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades. TF expression by circulating monocytes is associated with thrombotic and inflammatory complications in a variety of diseases. Transcriptional activation of the human TF gene in monocytic cells exposed to bacterial lipopolysaccharide (LPS) is mediated by binding of c-Rel/p65 heterodimers to a kappa B site in the TF promoter. Here, we report that a family of anti-inflammatory agents, known as the salicylates, inhibited LPS induction of TF activity and TF gene transcription in human monocytes and monocytic THP-1 cells at clinically relevant doses. Furthermore, sodium salicylate blocked the LPS-induced proteolytic degradation of I kappa B alpha, which prevented the nuclear translocation of c-Rel/p65 heterodimers. In contrast, two other nonsteroidal anti-inflammatory drugs, ibuprofen and indomethacin, did not inhibit LPS induction of the TF gene. These results indicated that salicylates inhibited LPS induction of TF gene transcription in monocytic cells by preventing nuclear translocation of c-Rel/p65 heterodimers. The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis, may be related to their ability to reduce monocyte gene expression.

Anti-Inflammatory Agents, Non-Steroidal